文献速递湿疹皮炎与荨麻疹

成人特应性皮炎主要合并症:基于Charlson合并症指数的全国登记研究

Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index.
PubMed 文献 · J Am Acad Dermatol · 2017-04-06

该研究利用丹麦全国登记数据,纳入2012年1月1日时≥18岁、由医院皮肤科医生诊断的特应性皮炎(AD)成人患者10,738例,并按年龄和性别1:4匹配一般人群对照42,952例。采用Charlson合并症指数(CCI)评估合并症负担,结果显示吸烟AD患者CCI评分显著高于对照(0.41 vs 0.13,P < .001),而非吸烟AD患者与对照相似(0.09 vs 0.08,P = .12);在重度AD患者中,吸烟者差异更明显(0.48 vs 0.14,P < .001),非吸烟者差异较小(0.10 vs 0.08,P = .01)。

要点

  • 吸烟的成人AD患者主要合并症负担显著高于一般人群对照。
  • 非吸烟AD患者总体合并症负担与对照人群相似。
  • 重度AD且吸烟者合并症风险差异最为突出。

核心结论

  • 基于全国数据,成人AD患者主要合并症风险较对照显著增加,风险差异主要见于重度疾病患者和吸烟者。

研究设计与样本

  • 全国登记研究,纳入丹麦≥18岁经医院皮肤科诊断的AD患者10,738例,按年龄和性别1:4匹配一般人群对照42,952例。
  • AD严重程度由是否接受系统性AD治疗判定,采用条件logistic回归分析。

主要发现

  • 吸烟AD患者CCI评分显著高于对照(0.41 vs 0.13,P < .001)。
  • 非吸烟AD患者CCI评分与对照相似(0.09 vs 0.08,P = .12)。
  • 重度AD吸烟者CCI评分差异更明显(0.48 vs 0.14,P < .001),非吸烟者差异较小(0.10 vs 0.08,P = .01)。

临床怎么用

  • 临床评估成人AD患者合并症负担时应关注吸烟状态和疾病严重程度。
  • 对重度AD患者及吸烟AD患者可考虑更积极的合并症筛查与管理。

局限性

  • 观察性研究不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a growing interest in comorbidities of adults with atopic dermatitis (AD). OBJECTIVES: To examine the burden of comorbidities in adult patients with AD using the Charlson comorbidity index (CCI) in nationwide registries. METHODS: All Danish patients ≥18 years on January 1, 2012 with AD diagnosed by a hospital dermatologist were included. Patients were age-and sex-matched in a 1:4 ratio with general population controls. Severity was determined by systemic AD treatment and analyzed by conditional logistic regression. RESULTS: In total, 10,738 adult patients with AD and 42,952 controls were analyzed. CCI score was significantly increased in smokers with AD compared with controls (0.41 vs 0.13, P < .001). Nonsmokers with AD had a similar CCI score as controls (0.09 vs 0.08, P = .12). In analyses restricted to patients with severe AD, a stronger difference in CCI score was observed for smokers (0.48 vs 0.14, P < .001) than for nonsmokers (0.10 vs 0.08, P = .01). LIMITATIONS: Observational studies do not establish cause and effect. CONCLUSION: On the basis of nationwide data, the risk for major comorbidities was significantly increased in adult patients with AD compared with controls. The risk difference was predominantly found in patients with severe disease and among smokers.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Thyssen JP, Skov L, Hamann CR, et al. Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index. J Am Acad Dermatol. 2017. PMID: 28392292. doi:10.1016/j.jaad.2017.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。